Literature DB >> 29516971

miR-150 contributes to the radioresistance in nasopharyngeal carcinoma cells by targeting glycogen synthase kinase-3β.

Yuanjian Huang1, Duxun Tan2, Juan Xiao1, Qiaoyun Li1, Xianfeng Zhang1, Zhiqiang Luo1.   

Abstract

INTRODUCTION: Radiotherapy has been the primary treatment for nasopharyngeal carcinoma (NPC), but the NPC radiocurability was severely limited with the radioresistance. The research suggested the important role of miRNAs in cancer therapeutic response.
MATERIALS AND METHODS: A radioresistant NPC cell line CNE-2R, we exposed CNE-2 cells to a range of radiation doses. Levels of miR-150 were measured by quantitative reverse-transcriptase polymerase chain reaction in CNE-2R and CNE-2 cells.
RESULTS: In this study, a cell line CNE-2R derived from parental CNE-2 was established via being exposed to stepwise escalated radiation dose. The expression of miR-150 was upregulated in CNE-2R cells. The radioresistance of CNE-2R cells was reversed after inhibiting miR-150 with specific inhibitor, while the radioresistance of CNE-2 cells was enhanced after the overexpression of miR-150. MiR-150b elicited these responses by directly targeting GSK3β. Moreover, GSK3β protein expression was downregulated in CNE-2R cells and restored GSK3β expression increased radiosensitivity of CNE-2R cells. Importantly, the negative correlation between miR-150 expression and GSK3β protein level was confirmed in the NPC tissues. High miR-150 expression and low GSK3β protein level were associated with poor prognosis in NPC patients.
CONCLUSION: Our findings suggested that miR-150-GSK3β axis may be a novel candidate for developing rational therapeutic strategies for NPC treatment.

Entities:  

Keywords:  GSK3β; miR-150; nasopharyngeal carcinoma; radioresistance

Mesh:

Substances:

Year:  2018        PMID: 29516971     DOI: 10.4103/jcrt.JCRT_682_17

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  9 in total

Review 1.  MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma.

Authors:  Yutong Tian; Lu Tang; Pin Yi; Qing Pan; Yaqian Han; Yingrui Shi; Shan Rao; Shiming Tan; Longzheng Xia; Jinguan Lin; Linda Oyang; Yanyan Tang; Jiaxin Liang; Xia Luo; Qianjin Liao; Hui Wang; Yujuan Zhou
Journal:  J Cancer       Date:  2020-04-06       Impact factor: 4.207

Review 2.  Role of non-coding RNAs and RNA modifiers in cancer therapy resistance.

Authors:  Xinyi Zhang; Kai Xie; Honghua Zhou; Yuwei Wu; Chan Li; Yating Liu; Zhaoya Liu; Qian Xu; Shuang Liu; Desheng Xiao; Yongguang Tao
Journal:  Mol Cancer       Date:  2020-03-02       Impact factor: 27.401

3.  Inhibition of cell proliferation and radioresistance by miR-383-5p through targeting RNA binding protein motif (RBM3) in nasopharyngeal carcinoma.

Authors:  Rui Ma; Peng Gao; Hua Yang; Jing Hu; Jing-Jing Xiao; Mei Shi; Li-Na Zhao
Journal:  Ann Transl Med       Date:  2021-01

Review 4.  Role of Non-coding RNAs on the Radiotherapy Sensitivity and Resistance of Head and Neck Cancer: From Basic Research to Clinical Application.

Authors:  Xixia Zhang; Jing Yang
Journal:  Front Cell Dev Biol       Date:  2021-02-11

5.  miR‑182‑5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression.

Authors:  Wei He; Hongyan Jin; Qian Liu; Quanxin Sun
Journal:  Mol Med Rep       Date:  2020-12-14       Impact factor: 2.952

Review 6.  Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?

Authors:  Camil Ciprian Mireștean; Roxana Irina Iancu; Dragoș Petru Teodor Iancu
Journal:  Curr Oncol       Date:  2022-02-02       Impact factor: 3.677

7.  Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs.

Authors:  Kaiguo Li; Xiaodong Zhu; Ling Li; Ruiling Ning; Zhongguo Liang; Fanyan Zeng; Fang Su; Shiting Huang; Xiaohui Yang; Song Qu
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

Review 8.  Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.

Authors:  Yuanbo Kang; Weihan He; Caiping Ren; Jincheng Qiao; Qiuyong Guo; Jingyu Hu; Hongjuan Xu; Xingjun Jiang; Lei Wang
Journal:  Signal Transduct Target Ther       Date:  2020-10-23

9.  MicroRNA hsa-miR-150-5p inhibits nasopharyngeal carcinogenesis by suppressing PYCR1 (pyrroline-5-carboxylate reductase 1).

Authors:  Zhiqun Li; Xiaoliu Zhou; Jiajun Huang; Zhencai Xu; Chengliang Xing; Junwei Yang; Xuejun Zhou
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.